Therapeutic interventions are currently focusing on VEGF’s vasculo–angiogenetic properties, for example in the treatment of various cancers [9,14], diabetic retinopathy [50], and age-dependent macular degeneration [10]. This evidence concerns the gene VEGFA and cancer.